Published in Blood Weekly, May 12th, 1997
In a recent study, researchers evaluated the effects of VEGF expression in an animal brain tumor model and evaluated the potential of antisense VEGF gene transfer for eventual therapy of human brain tumors. Takamitsu Oku, representing colleagues from the Memorial Sloan Kettering Cancer Center, New York, and the Beth Israel Hospital, Massachusetts, presented the study data at the American Association for Cancer Research conference, held April 12-16, 1997, in San Diego, California. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.